Great West Life Assurance CO Pacira Bio Sciences, Inc. Transaction History

Great West Life Assurance CO

$53.1 Billion
Q2 2024

A detailed history of Great West Life Assurance CO transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 47,958 shares of PCRX stock, worth $792,266. This represents 0.0% of its overall portfolio holdings.

Number of Shares

47,958

Previous 39,229 22.25%

Holding current value

$792,266

Previous $1.15 Million 19.74%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$25.5 - $31.51 $222,589 - $275,050	8,729 Added 22.25%	47,958 $1.37 Million
Q1 2024 May 13, 2024	BUY	$27.7 - $35.48 $68,003 - $87,103	2,455 Added 6.68%	39,229 $1.15 Million
Q4 2023 Feb 13, 2024	SELL	$26.32 - $34.31 $222,904 - $290,571	-8,469 Reduced 18.72%	36,774 $1.24 Million
Q3 2023 Nov 14, 2023	BUY	$30.68 - $40.09 $162,481 - $212,316	5,296 Added 13.26%	45,243 $1.39 Million
Q2 2023 Aug 10, 2023	SELL	$36.12 - $47.5 $427,841 - $562,637	-11,845 Reduced 22.87%	39,947 $1.6 Million
Q1 2023 May 12, 2023	BUY	$35.53 - $43.38 $178,538 - $217,984	5,025 Added 10.74%	51,792 $2.11 Million
Q4 2022 Feb 10, 2023	SELL	$38.19 - $57.45 $138,706 - $208,658	-3,632 Reduced 7.21%	46,767 $1.81 Million
Q3 2022 Nov 01, 2022	BUY	$51.24 - $58.89 $292,068 - $335,673	5,700 Added 12.75%	50,399 $2.68 Million
Q2 2022 Aug 12, 2022	BUY	$51.49 - $81.64 $2.3 Million - $3.65 Million	44,699 New	44,699 $2.61 Million
Q2 2022 Aug 09, 2022	SELL	$51.49 - $81.64 $1.98 Million - $3.14 Million	-38,506 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$60.03 - $76.49 $8,764 - $11,167	146 Added 0.38%	38,506 $3.02 Million
Q4 2021 Feb 14, 2022	BUY	$47.97 - $62.21 $25,040 - $32,473	522 Added 1.38%	38,360 $2.3 Million
Q2 2021 Aug 11, 2021	BUY	$59.18 - $69.99 $4,379 - $5,179	74 Added 0.2%	37,838 $2.3 Million
Q1 2021 May 17, 2021	SELL	$59.31 - $78.82 $262,090 - $348,305	-4,419 Reduced 10.48%	37,764 $2.65 Million
Q4 2020 Feb 16, 2021	SELL	$50.47 - $66.26 $240,741 - $316,060	-4,770 Reduced 10.16%	42,183 $2.52 Million
Q3 2020 Nov 17, 2020	BUY	$51.97 - $63.0 $2.42 Million - $2.93 Million	46,504 Added 10357.24%	46,953 $2.82 Million
Q3 2020 Nov 13, 2020	SELL	$51.97 - $63.0 $2.63 Million - $3.19 Million	-50,568 Reduced 99.12%	449 $26,000
Q2 2020 Aug 17, 2020	SELL	$30.8 - $52.47 $120,551 - $205,367	-3,914 Reduced 7.13%	51,017 $2.67 Million
Q1 2020 May 14, 2020	BUY	$28.4 - $50.7 $120,387 - $214,917	4,239 Added 8.36%	54,931 $1.84 Million
Q4 2019 Feb 11, 2020	BUY	$36.31 - $46.83 $1.84 Million - $2.37 Million	50,692 New	50,692 $2.3 Million
Q3 2019 Oct 25, 2019	SELL	$35.66 - $44.99 $132,262 - $166,867	-3,709 Closed	0 $0
Q2 2019 Jul 31, 2019	SELL	$36.57 - $47.97 $60,523 - $79,390	-1,655 Reduced 30.85%	3,709 $0
Q4 2018 Feb 12, 2019	BUY	$41.31 - $52.16 $63,162 - $79,752	1,529 Added 39.87%	5,364 $222,000
Q3 2017 Nov 09, 2017	BUY	$35.7 - $39.5 $136,909 - $151,482	3,835	3,835 $148,000

Others Institutions Holding PCRX

# of Institutions

302

Shares Held

51.6M

Call Options Held

378K

Put Options Held

1.53M

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $757M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.

Account

Great West Life Assurance CO Pacira Bio Sciences, Inc. Transaction History